FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2188361505> ?p ?o ?g. }

• W2188361505 abstract "BACKGROUND: The introduction of erythropoieti n has transformed the management of anaemia in CKD, with considerable benefits which includes enhanced quality of life, increased exercise capacity and improved cardiac function. There is paucity of data on the beneficial effects of this treatment from this environment. OBJECTIVE: The aim of this work was to study the pattern and response of anaemia and its response to treatment with recombinant human erythropoietin(r-HuEpo) in CKD patients in Nigeria. METHODS: This was a prospective study in which 20 CKD patients who satisfied the inclusion criteria were recruited consecutively. Subcutaneous r-HuEpo was administered to each of the study patients, starting with a weekly dose of 50 iu/Kg and titrated according to haemoglobin (Hb) response, which was monitored fortnightly throughout the study period with the aim of achieving a target Hb of 11g/dl. RESULTS: The patients studied were anaemic with mean Hb of 7.36 ± 1.05 g/dl. The anemia was normocytic normochromic in 85% of the patients. All the patients responded to treatment with r-HuEpo with the mean Hb rising from 6.74g/dl ± 0.70 to 11.64g/dl ± 0.37 and 7.64 g/dl ± 1.19 to 11.98 g/dl ± 0.45 g/dl in those on maintenance haemodialysis and pre-dialysis patients respectively. The patients reached the target Hb of 11g/dl within 8 weeks in predialytic CKD patients and within 10 weeks in those on maintenance haemodialysis. CONCLUSION: Anaemia is mostly normocytic normochromic in CKD patients in our environment and r-HuEpo therapy is effective in correcting the anaemia. WAJM 2009; 28(5): 295– 299." @default.
• W2188361505 created "2016-06-24" @default.
• W2188361505 creator A5006695781 @default.
• W2188361505 creator A5011724313 @default.
• W2188361505 creator A5029182112 @default.
• W2188361505 creator A5031886375 @default.
• W2188361505 creator A5032276522 @default.
• W2188361505 creator A5055015326 @default.
• W2188361505 creator A5068174835 @default.
• W2188361505 creator A5080737666 @default.
• W2188361505 creator A5088553505 @default.
• W2188361505 creator A5089463134 @default.
• W2188361505 date "2009-01-01" @default.
• W2188361505 modified "2023-09-27" @default.
• W2188361505 title "Anaemia and its Response to Treatment with Recombinant Human Erythropoietin in Chronic Kidney Disease Patients L'anémie et sa Réponse au Traitement avec l'Humain Recombinant Erythropoietin dans les Patients de Maladie Chroniques du Rein" @default.
• W2188361505 cites W1490071556 @default.
• W2188361505 cites W169281302 @default.
• W2188361505 cites W18205527 @default.
• W2188361505 cites W1899050407 @default.
• W2188361505 cites W1982012503 @default.
• W2188361505 cites W1982192445 @default.
• W2188361505 cites W1988165262 @default.
• W2188361505 cites W2029738096 @default.
• W2188361505 cites W2048085393 @default.
• W2188361505 cites W2093397637 @default.
• W2188361505 cites W2415328025 @default.
• W2188361505 cites W2434460620 @default.
• W2188361505 hasPublicationYear "2009" @default.
• W2188361505 type Work @default.
• W2188361505 sameAs 2188361505 @default.
• W2188361505 citedByCount "0" @default.
• W2188361505 crossrefType "journal-article" @default.
• W2188361505 hasAuthorship W2188361505A5006695781 @default.
• W2188361505 hasAuthorship W2188361505A5011724313 @default.
• W2188361505 hasAuthorship W2188361505A5029182112 @default.
• W2188361505 hasAuthorship W2188361505A5031886375 @default.
• W2188361505 hasAuthorship W2188361505A5032276522 @default.
• W2188361505 hasAuthorship W2188361505A5055015326 @default.
• W2188361505 hasAuthorship W2188361505A5068174835 @default.
• W2188361505 hasAuthorship W2188361505A5080737666 @default.
• W2188361505 hasAuthorship W2188361505A5088553505 @default.
• W2188361505 hasAuthorship W2188361505A5089463134 @default.
• W2188361505 hasConcept C104317684 @default.
• W2188361505 hasConcept C126322002 @default.
• W2188361505 hasConcept C159641895 @default.
• W2188361505 hasConcept C185592680 @default.
• W2188361505 hasConcept C2778248108 @default.
• W2188361505 hasConcept C2778534260 @default.
• W2188361505 hasConcept C2778653478 @default.
• W2188361505 hasConcept C2779978075 @default.
• W2188361505 hasConcept C40767141 @default.
• W2188361505 hasConcept C55493867 @default.
• W2188361505 hasConcept C71924100 @default.
• W2188361505 hasConcept C90924648 @default.
• W2188361505 hasConceptScore W2188361505C104317684 @default.
• W2188361505 hasConceptScore W2188361505C126322002 @default.
• W2188361505 hasConceptScore W2188361505C159641895 @default.
• W2188361505 hasConceptScore W2188361505C185592680 @default.
• W2188361505 hasConceptScore W2188361505C2778248108 @default.
• W2188361505 hasConceptScore W2188361505C2778534260 @default.
• W2188361505 hasConceptScore W2188361505C2778653478 @default.
• W2188361505 hasConceptScore W2188361505C2779978075 @default.
• W2188361505 hasConceptScore W2188361505C40767141 @default.
• W2188361505 hasConceptScore W2188361505C55493867 @default.
• W2188361505 hasConceptScore W2188361505C71924100 @default.
• W2188361505 hasConceptScore W2188361505C90924648 @default.
• W2188361505 hasLocation W21883615051 @default.
• W2188361505 hasOpenAccess W2188361505 @default.
• W2188361505 hasPrimaryLocation W21883615051 @default.
• W2188361505 isParatext "false" @default.
• W2188361505 isRetracted "false" @default.
• W2188361505 magId "2188361505" @default.
• W2188361505 workType "article" @default.